Skip to main content
Premium Trial:

Request an Annual Quote

Altona Diagnostics Nabs CE Mark for HIV-1 Viral Load PCR Assay

NEW YORK – Altona Diagnostics said on Thursday that it has received CE-IVD marking for and has launched its AltoStar HIV RT-PCR Kit 1.5.

The Hamburg, Germany-based firm's assay leverages reverse transcriptase quantitative PCR to allow users to amplify two separate regions of the HIV-1 genome to monitor viral load in HIV-infected patients.

The new kit contains master reagents, a no-template control, and quantification standards.

"With this CE-IVD [RT-qPCR] test for the monitoring of HIV-1 for use with the AltoStar workflow, we complete our AltoStar blood-borne virus product portfolio," Markus Hess, general manager of Altona Diagnostics, said in a statement. "The broad AltoStar assay menu now includes test systems for reliable viral load monitoring of blood-borne viruses like HIV, hepatitis B, and hepatitis C virus."

Last April, Altona received Emergency Use Authorization from the US Food and Drug Administration and the CE-IVD mark for its PCR-based SARS-CoV-2 test kit.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.